chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Per ED report, patient went to Pharmacy to get her 2nd COVID 19 vaccine on 3/29/2021 ~ 1 pm. She first felt fine, but ~ 2 pm she started having breakout of her rash, a dry cough and slightly raspy throat as well as facial swelling. She came to the Outpatient Center where she usually receives Xolair for her idiopathic anaphylaxis q 2 weeks, where she received a total of 300 mg of IV diphenhydramine and 40 mg of IV famotidine, after which they sent her to the ED for further observation and medication administration. Per ED note, allergic reaction/early anaphylaxis after 2nd COVID 19 vaccine, but no severe anaphylaxis or hypotension noted; no evidence of acute pharyngeal edema. In the ED pt was given 2 doses of epinephrine IM and further diphenhydramine. Later she was admitted for observation and further epinephrine and diphenhydramine administrations. She was discharged on 4/1/2021 in stable condition.
Sharp chest pain, burning of lungs, headaches, difficulty breathing pollution in the summer was bad as well. Tiredness. Interstitial cystitis pressure, burning, pain, heaviness, frequency of urination - treatments help make that 3-4 times a night. Muscle aches. Treatment for IC is bladder installations (Combo heparin lidocaine Novocain).
Information has been received from a physician concerning a female approximately 40-year-old who on approximately 18-SEP-2006 was vaccinated with a dose of MMR. She developed a reaction to the vaccination starting one week after the vaccination on approximately 25-SEP-2006, the symptoms progressed to an area of swelling and tenderness with severe pain and induration at the site of injection at two weeks after the injection. Unspecified medical attention was sought. At the time of the report, the patient had not recovered. Additional information has been requested.
Pain in right hip; quite severe at times.   Usually when I stand up from a lying or sitting position.  Moving does not always alleviate it.  Took Tylenol and seemed to be improving, but pain started getting worse a few days later and had muscle spasms occasionally.   Dr suggested  using Motrin instead of Tylenol during the day and 1/2 10 mg Baclofen tablet nightly.   Appears to be getting better at the moment, but that happened earlier before I went to the DR.
This case was reported by a pharmacist via call center representative and described the occurrence of pain in a 70-year-old female patient who received SHINGRIX (batch number P45M9, expiry date 27th February 2021) for prophylaxis. On 3rd September 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In September 2018, less than a day after receiving SHINGRIX, the patient experienced pain, fever, upset stomach, swelling and erythema. The patient was treated with TYLENOL and medication unknown, Ice Pack (NOS). On an unknown date, the outcome of the pain, fever, upset stomach, swelling and erythema were recovering/resolving. It was unknown if the reporter considered the pain, fever, upset stomach, swelling and erythema to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX in the left deltoid and that night, she experienced pain, swelling, fever and an upset stomach. The pharmacist stated that, the patient also reported redness and it was unknown about when and where the redness had occurred. In the morning (unspecified), the patient still had pain so the patient was recommended to take TYLENOL and use Ice. The patient reported to the pharmacist that, as of 5th September 2018 evening, her condition was 50 per cent better. No additional details were available.
Itchy Growing Swelling Rash in different spots, get rid of 1 batch and and another full blown batch in other spots comes in in different spots and lasts longer.  Driving me absolutely crazy itching.
awesome, like an energy boost; This is a spontaneous report from a non-contactable consumer. This consumer reported similar event for two patients. This is the first of two reports (reporter's sister). A 52-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 2 via an unspecified route of administration, on an unspecified date (Batch/Lot number was not reported) as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was previously administered the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, on an unspecified date (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. On an unspecified date after the second BNT162B2 vaccine, the patient felt "awesome, like an energy boost". The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021240906 Same reporter and suspect drug, similar event; different patient.
tested positive for COVID Narrative:  The patient tested positive for COVID 19 on 3/31/21. The patient was monitored as an outpatient. The symptoms were mild including increased mucous production and weakness.
have tested positive in less than four months of full vaccination; have tested positive in less than four months of full vaccination with symptoms; This is a spontaneous report received from a contactable other HCP (patient) via patient assistance. A patient of an unspecified age and gender received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration in Jan2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Patient historical vaccine included first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in Dec2020 as single dose for COVID-19 immunization. On 7Apr2021, patient had tested positive in less than four months of full vaccination and currently experiencing chills, loss of taste and extremely severe headache. Outcome for the events were unknown.  Information of batch details/Lot number has been requested.
Patient had mild fever and rash for 3 days. Came to office after 3 days and doctor diagnosed varicella.
Dissiness, nausea, headache, preassure in head, extreme tenetus, feel as if I am spinning, unsteady on my feet (could fall), tingling of all left side of my body, mostly in joints, sleuring speech, brain not connecting to mouth...slow.
Incorrect Dose. Moderna booster dose administered was 0.5 milliliters.  Booster dose should have been 0.25 milliliters.
never got 2nd dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 84-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 24th October 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 18-JUL-2022 Reporter's Comment: Pharmacist reported that a patient never got a 2nd dose of Shingrix. The vaccine administration facility was the same as primary reporter. The reporter's consent to follow-up did not asked but contact info above. Additional Supportive Information: Till the time of reporting the patient did not receive the 2nd dose of Shingrix vaccine, which led to incomplete course of vaccination. VAERS details was reported for 1st dose.
On 01-26-09 patient presented to Urgent Care with c/o crying, low grade fever, vomiting, diarrhea. Was admitted to hospital with diagnosis of Gastroenteritis/Dehydration. Re-admitted 1/29/09 for IVF. Re-admitted 2/4/09 for projectile vomiting.  3/11/2009 Received hospital medical records for multiple admissions Admit 1/26-1/28/2009. FINAL DX: acute gastroenteritis, secondary to rotavirus; fever; left inguinal hernia Records reveal patient experienced diarrhea x 2 da & vomiting x 1 da along with fever.  Seen in clinic & found to be dehydrated w/hernia.  Tx w/IVF.  Surgical consult done for hernia.  Improved & d/c to home w/PCP f/u.  Admit 1/29-1/30/2009. FINAL DX: vomiting, diarrhea & dehydration.   Patient continued to have symptoms & was readmitted overnight for rehydration.  Improved & d/c to home.  Admit 2/4-2/5/2009. FINAL DX: vomiting Patient developed new nonbilious projectile vomiting.
4th Covid shot total. 1st bivalent booster.   Partner came in to pharmacy today and said about 3 hours after vaccinations pt was "messed up". Stated patient had severe headache, hot  and cold, shivering, fever, bones were hurting and patient lost muscle control. Partner said she had to help him walk. Told her the flu like symptoms of minor fever and achy would be normal side effects of vaccines but the muscle control loss was not normal and I would report it to VAERS. Partner said pt was feeling better today.
Tested positive for Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for Covid-19) in a 54-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced COVID-19 (Tested positive for Covid-19). At the time of the report, COVID-19 (Tested positive for Covid-19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Apr-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. No treatment information mentioned.
pt recvd vax; fever, chills, sweating, h/a, aching of muscles & joints, weakness & n; (no vomiting); started 6 hrs after inject & lasted 48 hrs; 25jan94 tx w/ apap;
In the same day I had fever, headache, nausea, muscle aches. All these symptoms went away within 48-36h, except for nausea, which I am still having it 7 days later.
Having super weird dreams; Wake up sweating; Brain fog throughout the day; Feeling super off mentally; This spontaneous case was reported by a consumer and describes the occurrence of NIGHTMARE (having super weird dreams), HYPERHIDROSIS (wake up sweating), FEELING ABNORMAL (brain fog throughout the day) and MENTAL FATIGUE (Feeling super off mentally) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medication history was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NIGHTMARE (having super weird dreams), HYPERHIDROSIS (wake up sweating), FEELING ABNORMAL (brain fog throughout the day) and MENTAL FATIGUE (Feeling super off mentally). At the time of the report, NIGHTMARE (having super weird dreams), HYPERHIDROSIS (wake up sweating), FEELING ABNORMAL (brain fog throughout the day) and MENTAL FATIGUE (Feeling super off mentally) outcome was unknown.            No treatment medication was provided. No concomitant medication was provided. Action taken with respect to mRNA-1273 was not applicable.
Approx 20-30 minutes after vaccine, child felt sick, eyes rolled and he passed out in car, ? if shaking, was unconscious for 3-5 minutes, woke up without residual effect no fever, went to ER had CBC, NL, urine neg, BMP neg, EKG NL, Head UT WNL.
One minute after receiving flu vaccine, patient had syncope for approximately 10 seconds. Had patient continue to lie down with legs elevated for 15 minutes before allowing patient to leave the office. Patient got approximately 5 hours sleep night before.
Red, swollen band circling approximately  3/4 way around arm , approximately 2 ? below vaccination site, approximately 3? wide. Slightly itchy and tender. Developed 13 days after first dose.
Pt received pfizer vaccine first, followed by flucelvax. Pt fainted after flucelvax (10sec post flucelvax, <2min post pfizer covid vaccine). Pt was diaphoretic, hypotensive to 67/49 at nadir, several bouts of emesis, and was lethargic. Pt denied SOB, potential swelling of lower lip, but unable to determine change from baseline. EMS contacted, no medical intervention made.
Swollen, red, warm and pain in the arm; Swollen, red, warm and pain in the arm; Swollen, red, warm and pain in the arm; High fever; Very strong flu like symptoms; Headache; Very swollen lymphnodes under the arm, and neck on theside where the shot was taken andvery painful; Very swollen lymphnodes under the arm, and neck on theside where the shot was taken andvery painful; Sudden Sharp pains all over my body; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 10:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no known allergies. Concomitant medications included cetirizine hydrochloride (ZYRTEC), vitamin D (MANUFACTURER UNKNOWN) and probiotics from unknown dates and all for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Mar2021 at 09:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 02:00, the patient experienced swollen, red, warm and pain in the arm has lasted more than 1 week, slowly getting better. High fever lasted 3 days, OTC fever relief meds worked for 3 hrs and fever went back up, had to switch medication from acetaminophen to ibuprofen. Very strong flu like symptoms, lasted 3 days. Headache was not relieved until 2 days later. Very swollen lymph nodes under the arm and neck on the side where the shot was taken and very painful, still on going (as reported), although are less swollen. Sudden sharp pains all over body like pinches or electric shocks, randomly happening and in random places which lasted 5 days. The patient was slowly recovering (as reported) after 1 week. Therapeutic measures were taken as a result of the event high fever which included treatment with first acetaminophen (MANUFACTURER UNKNOWN) then ibuprofen (MANUFACTURER UNKNOWN). The events did not result in a visit to doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The clinical outcome of the events very swollen lymph nodes under the arm, and neck on the side where the shot was taken and very painful, headache, swollen, red, warm and pain in the arm was resolving and fever, very strong flu like symptoms was resolved on 03Apr2021. The clinical outcome of the event sudden sharp pains all over the body like pinches or electric shocks, randomly happening and in random places was resolved on 05Apr2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Numbness and tingling in both feet and legs below the knees. Progressed to one leg's numbness and tingling going above the knee to the mid thigh area.  Dr said it was mild Guillain-Barre Syndrome.
Patient arrived for 1st dose Pfizer vaccine.  4 minutes after receiving the vaccine, he started to feel dizzy, became diaphoretic, palor, and weak.  Patient lowered himself to the ground.  Took patient's VS.  Patient's BP 95/51, HR 41, 18 RR, 98% O2 on RA.  Patient started to feel better.  He sat back up in the chair with assist.  He ended up having change in LOC (AO x 1) and not responding to our questions.  He was diaphoretic and oxygen sat was 93% on RA.  Transferred patient to a gurney, administered O2 6L via NC and transported patient to ED for further evaluation.
Mother called at about 9:30-9:45 am on 8-1-12 an stated child's arm had a swollen reddened whelp at site of "chicken pox shot" that was size of baseball in diameter which began before child went to bed on night of 7-31-12, had given child a dose of BENADRYL, marked the area and when child awoke this am, the area had passed the marked area by about 1/2". Instructed them to give child BENADRYL every 4 hours & if worsens to take child to MD or to ER.
After the 2nd dose vaccine, I had the normal flu-like symptoms but they were milder. I had low-grade fever up to 100 degrees, chills, mild body aches and fatigue. The symptoms took a week to resolve. On 7/13/2021 that evening, I had fever up to 102 degrees and body aches. I went and got tested for COVID and it was positive. My doctor recommended high-dose vitamin regimen. It is day 21 post-positive COVID test and I am still having coughing, chest tightness, mild fever and increased anxiety from having the infection. I am getting my taste and smell back. The doctor did order blood work and a chest x-ray, which came back normal. I was prescribed prednisone. I am getting a very weird sensation of warm water being poured over my left foot. This sensation is very random and will only last for a few seconds.
with metastatic Ewing sarcoma who was admitted for week 3 consolidation after a one-week delay for low counts. Upon admission he received aggressive hydration and anti-emetics prior to daily ETOP/IFOS x 5 days with concurrent radiation tx.  Discharged to home. Hospital admission within 6 weeks of receiving the COVID vaccine.
A employee at our practice that was in charge of covid vaccine here never entered covid vaccine's into system. When  I went to enter all vaccine's into system I noticed this lot number states it expired 5/2022 but the card that comes in the package of vaccine states used by date is 09/30/2022. When I contacted Hospital pharmacy I was told that the expiration date is extended 12 months from manufacture date. I was also informed there is a website to check expiration dates. I put the lot number in it states 8/31/2022. Management at hospital pharmacy contacted pfizer and they confirmed that this vaccine is expired.
Loss of vision; Possible lowgrade central retinal occlusion; retinal venous dilation; Decreased vision; Unexplained Retinal Hemorrhages; A spontaneous report was received from an ophthalmologist retinal specialist concerning a 46-year-old, male patient who received Moderna's COVID-19 Vaccine and developed loss of vision, decreased vision, unexplained retinal hemorrhages, retinal venous dilation, and possible low grade central retinal occlusion.     The patient's medical history was not provided. Concomitant product use was not provided by the reporter.   On 23 Dec 2020, approximately four days prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Lot number: 025J20-2A) intramuscularly in the arm for prophylaxis of COVID-19 infection.   On 27 Dec 2020, the patient experienced decreased vision.  On 29 Dec 2020, the physician examined the patient. There was some retinal hemorrhage, venous dilation, and possible low grade central retinal occlusion. Lab work was requested by the physician and results were pending. Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was not provided.   The outcome of the events, loss of vision, decreased vision, unexplained retinal hemorrhages, retinal venous dilation, and possible low grade central retinal occlusion were unknown.; Reporter's Comments: This case concerns a  46 year old male patient. The patient's medical history is not provided. The patient experienced a serious, unexpected event of loss of vision, unexplained retinal hemorrhages, retinal venous dilation, and possible low grade  central retinal occlusion. The event occurred 4 days after first dose of the mRNA-1273. Very limited information regarding this event has been provided at this time.  Based on temporal association between the use of mRNA-1273 and the event, a causal relationship cannot be excluded. Additional information are required for further assessment.
slept over 20 hours day 4, plus 12 day 5; Joint and muscle pain; Joint and muscle pain; extreme fatigue/exhausted; Congested with runny nose; Congested with runny nose; itchy eyes; generally feeling ill; This is a spontaneous report from a contactable other healthcare professional reported for herself. A 40-year-old female patient (patient was not pregnant at the time of vaccination) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL3247, Expiry date: unknown) intramuscular, administered in Arm Left on 29Jan2021 09:45 am (at the age of 40-years-old) at a single dose for covid-19 immunisation. Medical history included sinus tachycardia, panic disorder, depression, chronic fatigue syndrome, PCOS. Allergies to medications, food, or other products was Penicillin. Concomitant medication patient received within 2 weeks of vaccination included Metformin 500mg, Metoprolol 50 mg, Paroxetine 50 mg and vitamin D. The patient previously took first dose of BNT162B2 (lot number: EL0140) on 08Jan2021 on right arm at a single dose for covid-19 immunisation and 2 weeks or so after first shot, noticed severe itching on my left upper thigh with bumps and after this shot, itching has spread to face and arms. The patient experienced joint and muscle pain, extreme fatigue/exhausted on 31Jan2021, slept over 20 hours day 4, plus 12 day 5 on 01Feb2021 and congested with runny nose, itchy eyes, generally feeling ill in 2021. The event was considered as non-serious. Facility where the most recent COVID-19 vaccine was administered was Nursing Home/Senior Living Facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. No treatment was received for the adverse event. The patient underwent lab tests and procedures which included Oropharyngeal: negative on 01Feb2021. The outcome of all the events was not recovered.
Patient complained feeling a little light headed . We checked her blood pressure which was 89/67 mmHg, pulse 80. Pulse Ox 99/70. We laid her flat and elevated her legs. After a few minutes she felt better. Her blood pressure was checked and improved to 112/81 mmHg, pulse 77. We had patient stayed in store for at least another 30 minutes. Patient reported feeling fine and no further adverse reactions. Patient was released with her boyfriend.
THREE DAYS OF SYMPTOMS, DIZZINESS,WEAKNESS,PAIN INJECTION SITE,HEADACHE,TIRED,MUSCULAR PAIN CHILLS,JOINT PAIN,FEVER,SWELLING ON INJECTION SITE,NAUSEA,INFLAMATION OF NODES.
Itching began 12/01/09 10 am, 15 minutes after having been immunized with H1N1 vaccine in his left arm and then spread down the left arm to his wrist. At 2 pm on 12/01/09 the right arm and both lower legs began to itch. At 7 to 8 pm  on 12/01/09, his back and chest itched. There has been no rash or any other symptoms. On 12/3/09 he was still experiencing some itching on his left arm, lower legs and upper chest. He had not sought medical attention. On 12/4/09 - the interviewer telephoned patient to determine if he continued to have itching and if he had sought medical attention. A message was left on his telephone, however by 12/10/09, patient had not returned the call.